Nestlé Health Science is celebrating five years of innovation at its global research and development hub in Bridgewater. Co-located at the company’s U.S. headquarters on Route 202, the Nestlé Product ...

As weight-loss medications become more popular, Nestlé Health Science wants to ensure that consumers who are taking the drugs have access to comprehensive nutritional support. The global leader in ...

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement ...

VEVEY, SWITZERLAND – Nestle Health Science, a business unit of Nestle SA, is acquiring a majority stake in Orgain, Irvine, Calif., a plant-based nutrition company that manufactures and markets powders ...

BOSTON--(BUSINESS WIRE)--Amwell ® (NYSE: AMWL), a leader in hybrid health care enablement, today announced a collaboration with Nestlé Health Science, a global leader in the science of nutrition, to ...

Seres Therapeutics has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with ...

VEVEY, SWITZERLAND — Nestle Health Science, a business of Nestle SA, has entered an agreement to acquire IM HealthScience, Boca Raton, Fla. Terms were not disclosed. IM HealthScience develops products ...

Nestlé (OTCPK:NSRGY) (OTCPK:NSRGF) plans to maintain ownership of its health science unit, Chairman Paul Bulcke said in an interview with NZZ am Sonntag newspaper published on Sunday. The ...

ZURICH (Reuters) -Nestle intends to keep its Health Science unit, Chairman Paul Bulcke said in a newspaper interview published on Sunday, after the food giant announced it was replacing its CEO Mark ...

In 2020, Nestlé Health Science agreed to acquire a majority stake in Vital Proteins, adding the brand to its other vitamin, mineral, supplement and wellness brands, including Atrium Innovations, ...

Seres Therapeutics has announced a new deal with its longtime partner, Nestlé Health Science, to bring Seres’ lead experimental microbiome drug to the U.S. market. That drug, SER-109, has been tested ...

Nestlé plans to retain its Health Science unit, chairman Paul Bulcke has said in an interview discussing the change in CEO at the world’s largest food group. In the wake of last week’s announcement ...